BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12615444)

  • 1. Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice.
    Iqbal M; Lin W; Jabbal-Gill I; Davis SS; Steward MW; Illum L
    Vaccine; 2003 Mar; 21(13-14):1478-85. PubMed ID: 12615444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection.
    Kumar M; Behera AK; Lockey RF; Zhang J; Bhullar G; De La Cruz CP; Chen LC; Leong KW; Huang SK; Mohapatra SS
    Hum Gene Ther; 2002 Aug; 13(12):1415-25. PubMed ID: 12215263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-specific CTL responses induced by an H-2K(d)-restricted, motif-negative 15-mer peptide from the fusion protein of respiratory syncytial virus.
    Jiang S; Borthwick NJ; Morrison P; Gao GF; Steward MW
    J Gen Virol; 2002 Feb; 83(Pt 2):429-438. PubMed ID: 11807236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses.
    Simmons CP; Hussell T; Sparer T; Walzl G; Openshaw P; Dougan G
    J Immunol; 2001 Jan; 166(2):1106-13. PubMed ID: 11145691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of immunization with a peptide cocktail inducing antibody, helper and cytotoxic T-cell responses on protection against respiratory syncytial virus.
    Hsu SC; Chargelegue D; Obeid OE; Steward MW
    J Gen Virol; 1999 Jun; 80 ( Pt 6)():1401-1405. PubMed ID: 10374957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of balanced immunity in BALB/c mice by vaccination with a recombinant fusion protein containing a respiratory syncytial virus G protein fragment and a CTL epitope.
    Zeng RH; Gong W; Fan CF; Wang YF; Mei XG
    Vaccine; 2006 Feb; 24(7):941-7. PubMed ID: 16159685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective cytotoxic T lymphocyte responses against paramyxoviruses induced by epitope-based DNA vaccines: involvement of IFN-gamma.
    Hsu SC; Obeid OE; Collins M; Iqbal M; Chargelegue D; Steward MW
    Int Immunol; 1998 Oct; 10(10):1441-7. PubMed ID: 9796910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in mice.
    Martinez X; Li X; Kovarik J; Klein M; Lambert PH; Siegrist CA
    Eur J Immunol; 1999 Oct; 29(10):3390-400. PubMed ID: 10540351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of a mimotope-based synthetic peptide vaccine against respiratory syncytial virus.
    Steward MW
    Biologicals; 2001; 29(3-4):215-9. PubMed ID: 11851318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cytolytic activity of pulmonary CD8+ lymphocytes, induced by infection with a vaccinia virus recombinant expressing the M2 protein of respiratory syncytial virus (RSV), correlates with resistance to RSV infection in mice.
    Kulkarni AB; Connors M; Firestone CY; Morse HC; Murphy BR
    J Virol; 1993 Feb; 67(2):1044-9. PubMed ID: 8419638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of respiratory syncytial virus titer in the lungs of mice after intranasal immunization with a chimeric peptide consisting of a single CTL epitope linked to a fusion peptide.
    Hsu SC; Chargelegue D; Steward MW
    Virology; 1998 Jan; 240(2):376-81. PubMed ID: 9454711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
    Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
    Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion of DsbA to the N-terminus of CTL chimeric epitope, F/M2:81-95, of respiratory syncytial virus prolongs protein- and virus-specific CTL responses in Balb/c mice.
    Fan CF; Zeng RH; Sun CY; Mei XG; Wang YF; Liu Y
    Vaccine; 2005 Apr; 23(22):2869-75. PubMed ID: 15780735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope.
    Mok H; Lee S; Wright DW; Crowe JE
    Vaccine; 2008 Sep; 26(37):4775-82. PubMed ID: 18662734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 ligand (CD154) enhances the Th1 and antibody responses to respiratory syncytial virus in the BALB/c mouse.
    Tripp RA; Jones L; Anderson LJ; Brown MP
    J Immunol; 2000 Jun; 164(11):5913-21. PubMed ID: 10820273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of different DNA delivery systems for protection against respiratory syncytial virus infection in the murine model: gene-gun delivery induces IgG in the lung.
    Tree JA; Bembridge G; Hou S; Taylor G; Fashola-Stone E; Melero J; Cranage MP
    Vaccine; 2004 Jun; 22(19):2438-43. PubMed ID: 15193407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-immunization of BALB/c mice with recombinant immunogens containing G protein fragment and chimeric CTL epitope of respiratory syncytial virus induces enhanced cellular immunity and high level of antibody response.
    Fan CF; Mei XG
    Vaccine; 2005 Aug; 23(35):4453-61. PubMed ID: 15935522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2.
    Zeng R; Qi X; Gong W; Mei X; Wei L; Ma C; Yin X
    Vaccine; 2007 Oct; 25(42):7422-8. PubMed ID: 17850930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of a single viral epitope on T cell response and disease after infection of mice with respiratory syncytial virus.
    Vallbracht S; Jessen B; Mrusek S; Enders A; Collins PL; Ehl S; Krempl CD
    J Immunol; 2007 Dec; 179(12):8264-73. PubMed ID: 18056370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.